16 | Peptides (Polypeptides)IBA
12/2014
-
02/2008 |
11 | LactamsIBA
12/2014
-
02/2008 |
11 | alpha-MSHIBA
04/2013
-
02/2008 |
9 | Type 1 Melanocortin ReceptorIBA
12/2014
-
08/2009 |
7 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
08/2012
-
04/2009 |
6 | Melanocyte-Stimulating Hormones (MSH)IBA
12/2014
-
08/2009 |
5 | AcidsIBA
12/2014
-
04/2011 |
5 | N-glycylglutamic acidIBA
06/2012
-
02/2008 |
3 | Amino AcidsFDA Link
12/2014
-
08/2009 |
3 | arginylprolineIBA
06/2012
-
04/2009 |
3 | lysinenorleucineIBA
06/2012
-
04/2009 |
3 | arginyl-glycyl-aspartic acidIBA
11/2010
-
08/2009 |
2 | Biological ProductsIBA
04/2015
-
06/2010 |
2 | triazacyclononaneIBA
08/2012
-
06/2012 |
2 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
08/2012
-
06/2012 |
2 | tryptophylglycineIBA
06/2012
-
11/2009 |
2 | Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2011
-
08/2011 |
2 | ciprofloxacin dithiocarbamateIBA
06/2010
-
10/2008 |
1 | Ethanol (Ethyl Alcohol)IBA
01/2022 |
1 | GlucansIBA
01/2022 |
1 | NF-kappa B (NF-kB)IBA
10/2021 |
1 | Immune Checkpoint InhibitorsIBA
10/2020 |
1 | Immunoglobulin FragmentsIBA
10/2020 |
1 | Biomarkers (Surrogate Marker)IBA
10/2020 |
1 | sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
04/2015 |
1 | omega-aminocaprylic acidIBA
12/2014 |
1 | EDDA (NiEDDA)IBA
12/2014 |
1 | HydrocarbonsIBA
12/2014 |
1 | Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
12/2014 |
1 | Dextran SulfateIBA
03/2014 |
1 | Methotrexate (Mexate)FDA LinkGeneric
03/2014 |
1 | Pharmaceutical PreparationsIBA
03/2014 |
1 | Therapeutic UsesIBA
03/2014 |
1 | Chelating AgentsIBA
04/2013 |
1 | LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
08/2011 |
1 | Radioisotopes (Radionuclides)IBA
04/2011 |
1 | Ac- Cys- Cys- Glu- His- D- Phe- Arg- Trp- Cys- Lys- Pro- Val- NH2IBA
11/2010 |
1 | IntegrinsIBA
11/2010 |
1 | Deoxyglucose (2 Deoxy D glucose)IBA
04/2009 |
1 | ACTH (7-10)IBA
04/2009 |